Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis
Yin Tang,1– 5,* Yuzhe He,1– 4,* Lidong Wu1– 4 1Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, People’...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/hsacirc0078767-enhances-osteosarcoma-chemoresistance-to-doxorubicin-th-peer-reviewed-fulltext-article-PGPM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850130477883588608 |
|---|---|
| author | Tang Y He Y Wu L |
| author_facet | Tang Y He Y Wu L |
| author_sort | Tang Y |
| collection | DOAJ |
| description | Yin Tang,1– 5,* Yuzhe He,1– 4,* Lidong Wu1– 4 1Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China; 3Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China; 4Clinical Research Center of Motor System Disease of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China; 5Department of Orthopedic Surgery, Ningbo No.2 hospital, Ningbo, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lidong Wu, Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China, Tel +86-057187783777, Email wulidong777@sina.comBackground: Osteosarcoma (OS) is a primary malignancy of bone. The emergence of chemoresistance represents a persistent barrier to effective cancer patient care. This analysis sought to examine hsa_circ_0078767 as a mediator of doxorubicin (DOX) resistance in OS.Methods: Levels of hsa_circ_0078767, miR-188-3p, and glutathione peroxidase 4 (GPX4) in OS clinical tissue samples and cell lines were evaluated by quantitative polymerase chain reaction (qPCR) and Western blotting. Associations between hsa_circ_0078767 levels in clinical samples and patient overall survival were assessed with Kaplan-Meier curves. CCK-8 assays were utilized as a means of examining DOX half-inhibitory concentration (IC50) values. RNA immunoprecipitation and pull-down, as well as reporter assays, investigated interactions between hsa_circ_0078767, miR-188-3p, and GPX4 within OS cells exhibiting DOX resistance.Results: OS patient tissues and cell lines resistant to DOX exhibited elevated hsa_circ_0078767 and GPX4 expression together with a reduction in miR-188-3p levels. Inhibiting hsa_circ_0078767 expression contributed to a profound decrease in the ability of OS tumors to resist DOX. Mechanistically, it was determined that hsa_circ_0078767 can enhance DOX chemoresistance through its ability to bind and sequester miR-188-3p, which otherwise negatively modulates GPX4 to enhance chemosensitivity. Accordingly, the sequestration of miR-188-3p by hsa_circ_0078767 led to the derepression and upregulation of GPX4.Conclusion: Hsa_circ_0078767 was found to modulate miR-188-3p/GPX4 signaling to enhance OS cell resistance to DOX treatment and facilitate disease progression. As such, hsa_circ_0078767 may represent a valuable biomarker or target for use in the context of OS patient management.Keywords: GPX4, hsa_circ_0078767, doxorubicin, miR-188-3p, osteosarcoma |
| format | Article |
| id | doaj-art-be3604f324ee4e488dcef32004da30c5 |
| institution | OA Journals |
| issn | 1178-7066 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Pharmacogenomics and Personalized Medicine |
| spelling | doaj-art-be3604f324ee4e488dcef32004da30c52025-08-20T02:32:41ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662024-11-01Volume 1751152097487Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 AxisTang YHe YWu LYin Tang,1– 5,* Yuzhe He,1– 4,* Lidong Wu1– 4 1Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China; 3Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China; 4Clinical Research Center of Motor System Disease of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China; 5Department of Orthopedic Surgery, Ningbo No.2 hospital, Ningbo, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lidong Wu, Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China, Tel +86-057187783777, Email wulidong777@sina.comBackground: Osteosarcoma (OS) is a primary malignancy of bone. The emergence of chemoresistance represents a persistent barrier to effective cancer patient care. This analysis sought to examine hsa_circ_0078767 as a mediator of doxorubicin (DOX) resistance in OS.Methods: Levels of hsa_circ_0078767, miR-188-3p, and glutathione peroxidase 4 (GPX4) in OS clinical tissue samples and cell lines were evaluated by quantitative polymerase chain reaction (qPCR) and Western blotting. Associations between hsa_circ_0078767 levels in clinical samples and patient overall survival were assessed with Kaplan-Meier curves. CCK-8 assays were utilized as a means of examining DOX half-inhibitory concentration (IC50) values. RNA immunoprecipitation and pull-down, as well as reporter assays, investigated interactions between hsa_circ_0078767, miR-188-3p, and GPX4 within OS cells exhibiting DOX resistance.Results: OS patient tissues and cell lines resistant to DOX exhibited elevated hsa_circ_0078767 and GPX4 expression together with a reduction in miR-188-3p levels. Inhibiting hsa_circ_0078767 expression contributed to a profound decrease in the ability of OS tumors to resist DOX. Mechanistically, it was determined that hsa_circ_0078767 can enhance DOX chemoresistance through its ability to bind and sequester miR-188-3p, which otherwise negatively modulates GPX4 to enhance chemosensitivity. Accordingly, the sequestration of miR-188-3p by hsa_circ_0078767 led to the derepression and upregulation of GPX4.Conclusion: Hsa_circ_0078767 was found to modulate miR-188-3p/GPX4 signaling to enhance OS cell resistance to DOX treatment and facilitate disease progression. As such, hsa_circ_0078767 may represent a valuable biomarker or target for use in the context of OS patient management.Keywords: GPX4, hsa_circ_0078767, doxorubicin, miR-188-3p, osteosarcomahttps://www.dovepress.com/hsacirc0078767-enhances-osteosarcoma-chemoresistance-to-doxorubicin-th-peer-reviewed-fulltext-article-PGPMgpx4hsa_circ_0078767doxorubicinmir-188-3posteosarcoma |
| spellingShingle | Tang Y He Y Wu L Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis Pharmacogenomics and Personalized Medicine gpx4 hsa_circ_0078767 doxorubicin mir-188-3p osteosarcoma |
| title | Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis |
| title_full | Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis |
| title_fullStr | Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis |
| title_full_unstemmed | Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis |
| title_short | Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis |
| title_sort | hsa circ 0078767 enhances osteosarcoma chemoresistance to doxorubicin through the regulation of the mir 188 3p gpx4 axis |
| topic | gpx4 hsa_circ_0078767 doxorubicin mir-188-3p osteosarcoma |
| url | https://www.dovepress.com/hsacirc0078767-enhances-osteosarcoma-chemoresistance-to-doxorubicin-th-peer-reviewed-fulltext-article-PGPM |
| work_keys_str_mv | AT tangy hsacirc0078767enhancesosteosarcomachemoresistancetodoxorubicinthroughtheregulationofthemir1883pgpx4axis AT hey hsacirc0078767enhancesosteosarcomachemoresistancetodoxorubicinthroughtheregulationofthemir1883pgpx4axis AT wul hsacirc0078767enhancesosteosarcomachemoresistancetodoxorubicinthroughtheregulationofthemir1883pgpx4axis |